Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases: 2019-2024

Historic Current Leases for CorMedix (CRMD) over the last 5 years, with Dec 2024 value amounting to $167,922.

  • CorMedix's Current Leases rose 416.63% to $844,431 in Q3 2025 from the same period last year, while for Sep 2025 it was $844,431, marking a year-over-year increase of 416.63%. This contributed to the annual value of $167,922 for FY2024, which is N/A change from last year.
  • As of FY2024, CorMedix's Current Leases stood at $167,922, which was up 24.39% from $135,000 recorded in FY2022.
  • CorMedix's Current Leases' 5-year high stood at $167,922 during FY2024, with a 5-year trough of $109,128 in FY2020.
  • Moreover, its 2-year median value for Current Leases was $151,461 (2022), whereas its average is $151,461.
  • Data for CorMedix's Current Leases shows a peak YoY spiked of 5,326.55% (in 2020) over the last 5 years.
  • CorMedix's Current Leases (Yearly) stood at $109,128 in 2020, then climbed by 11.22% to $121,368 in 2021, then grew by 11.23% to $135,000 in 2022, then reached $167,922 in 2024.